`

Tagged: Phase 1 and 2 Protocol Development

BBCR brings deep expertise in early-stage development, including Phase 1 and Phase 2 process and strategy, spanning pre-clinical work through pre-IND. Our early drug development capabilities encompass clinical strategy and planning, including the creation of target product profiles and the design of clinical protocols.

February 10th, 2026 | Phase 1 and 2 Protocol Development

Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process and strategy. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.    

BBCR has extensive experience in early development Phase 1 and 2 process and strategy, from pre-clinical to pre-IND. Our early drug development experience includes the development of clinical strategy and plan, including target product profiles and clinical protocols.

July 19th, 2023 | Phase 1 and 2 Protocol Development

Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process and strategy. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.